Merck’s drug for bacterial infection leads to fatal diarrhea
merck
December, 24 2024
(Web Desk) Merck will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug Administration's website showed on Monday.

The antibody drug, Zinplava, was first approved by the regulator in 2016 to prevent the recurrence of Clostridioides difficile infections (CDI).

CDI is generally caused by prolonged use of antibiotics, and can lead to potentially fatal diarrhea and inflammation of the colon.

The drugmaker did not immediately comment on the matter.

Zinplava will be discontinued on Jan. 31, the regulator s website showed, but no reason was cited for the decision.

          
Must Read
Image
Alkhidmat Foundation holds ceremony to honour Palestinian graduates of dental surgery
May, 2 2025
Image
Commonwealth scholarships open for Pakistani students — Here’s what you need to know
May, 1 2025
Image
Indian mob lynches man for shouting ‘Pakistan Zindabad’ during cricket match
April, 29 2025
Image
GAME. SET. RECORD BROKEN - WALEE HITS 1.1 BILLION VIEWS
April, 29 2025